Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Dawn J. Caster

ResearcherPublications, citations & collaboration network

Dawn J. Caster is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 70 works, 2,577 citations, an h-index of 20 and an i10-index of 28.

70
Works
2,577
Citations
20
h-index
28
i10-index

How has Dawn J. Caster's publication output changed over time?

ScholarIQpublication output · 2013–2023

Output grew500% over the shown period — from 1 works in 2013 to 6 in 2023.

1
1
2
1
1
6
201320162019202020212023

What are the most-cited papers on Dawn J. Caster?

ScholarIQmost cited works
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Brad H. Rovin, Y K Onno Teng, Ellen M. Ginzler, Cristina Arriens, Dawn J. Caster, Juanita Romero‐Díaz, Keisha L. Gibson, Joshua M. Kaplan, Laura Lisk, Sandra Navarra, Samir V. Parikh, Simrat Randhawa, Neil Solomons, Robert B. Huizinga
The Lancet. 2021619 Citations
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
Brad H. Rovin, Brad H Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, Charles E. Alpers, Stewart Bieler, Dong-Wan Chae, Ulysses Diva, Jürgen Floege, Loreto Gesualdo, Jula K. Inrig, Donald E. Kohan, Radko Komers, Laura Ann Kooienga, Richard Lafayette, Bart Maes, Robert Małecki, Alex Mercer, Irene L. Noronha, Se Won Oh, Chen Au Peh, Manuel Praga, Priscila Preciado, Jai Radhakrishnan, Michelle N. Rheault, William E. Rote, Sydney C W Tang, Vladimir Tesar, Howard Trachtman, Hernán Trimarchi, James A Tumlin, Muh Geot Wong, Vlado Perkovic, Isabella Abbasciano, Catarina Abrantes, Simone Accarino, Sharon G. Adler, Annika Adoberg, Rouzbeh Afsari, Syeda B. Ahmad, Jafar Ahmed, Wooin Ahn, Bamidele Ajayi, Dariusz Aksamit, Saif Al‐Chalabi, É. Alamartine, Bassam Alchi, Mohammad Ali, Roberta Aliotta, Salem Almaani, Catarina Almeida, Edgar Almeida, Francisco de la Prada Álvarez, Patrícia Marques‐Alves, Francesca Annese, Gerald Appel, Alberto Ortiz Arduan, Maria Arena, Marta Calvo Arevalo, Dariush Arfaania, Carlos Arias, Emma Calatayud Aristoy, Eglė Ašakienė, Sarah Ashley, Ali Assefi, Alba Atenza, Asta Auerbach, Hanna Augustyniak-Bartosik, M Avella, Jonathan Ayling-Smith, Isabelle Ayoub, Christine Ayvazyan, Rocco Baccaro, Asha Bailey, Bruce Baker, Saravanan Balamuthusamy, José Ballarín, Rui Barata, Jerko Barbić, Dunja Barisic, Jonathan Barratt, José C. Barreto, Clara Barrios, Mirco Belingheri, Anna Benesova, Ana Ávila Bernabéu, Wanja Bernhardt, Shamik Bhadra, Luigi Biancone, Anne Blanchard, Elena Boaglio, Davide Bolignano, Andrew S. Bomback, Gustavo Andres Useche Bonilla, M Bordoli, Bhadran Bose, Neil Boudville, Donald Brandon, Donald Brandon, Karen Brown
The Lancet. 2023282 CitationsOPEN ACCESS
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Jürgen Floege, Sean Barbour, Daniel Cattran, Jonathan J. Hogan, Patrick H. Nachman, Sydney Tang, Jack F.M. Wetzels, Michael Cheung, David C. Wheeler, Wolfgang C. Winkelmayer­, Brad H. Rovin, Sharon G. Adler, Charles E. Alpers, Isabelle Ayoub, Arvind Bagga, Jonathan Barratt, Dawn J. Caster, Daniel T.M. Chan, Anthony Chang, Jason Choo, H. Terence Cook, Rosanna Coppo, Fernando C. Fervenza, Agnes B. Fogo, J. G. Fox, Keisha L. Gibson, Richard J. Glassock, David C.H. Harris, Elisabeth M Hodson, Elion Hoxha, Kunitoshi Iseki, J. Charles Jennette, Vivekanand Jha, David W. Johnson, Shinya Kaname, Ritsuko Katafuchi, A. Richard Kitching, Richard Lafayette, Philip Kam‐Tao Li, Adrian Liew, Jicheng Lv, Ana Malvar, Shoichi Maruyama, Juan M. Mejía‐Vilet, Marcus J. Moeller, Chi Chiu Mok, Carla Nester, Eisei Noiri, Michelle M. O’Shaughnessy, Seza Özen, Samir M. Parikh, Hyeong Cheon Park, Chen Au Peh, William F. Pendergraft, Matthew C. Pickering, Évangéline Pillebout, Jai Radhakrishnan, Manish Rathi, Dario Roccatello, Pierre Ronco, William E. Smoyer, Vladimı́r Tesař, Joshua M. Thurman, Hernán Trimarchi, Marina Vivarelli, Giles Walters, Angela Yee‐Moon Wang, Scott E. Wenderfer
Kidney International. 2019264 CitationsOPEN ACCESS
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers, Jonathan Barratt, Stewart Bieler, Ulysses Diva, Jula K. Inrig, Radko Komers, Alex Mercer, Irene L. Noronha, Michelle N. Rheault, William E. Rote, Brad H. Rovin, Howard Trachtman, Hernán Trimarchi, Muh Geot Wong, Vlado Perkovic, Eric Alarmartine, Jonathan Barratt, Dong‐Wan Chae, Lucia Del Vecchio, Jürgen Floege, Shang‐Jyh Hwang, Bojan Jelaković, Bart Maes, Robert Małecki, Marius Miglinas, Fernando Nolasco, M Praga, Kannaiyan S Rabindranath, Mai Rosenberg, Brad H. Rovin, Sydney Tang, Vladmir Tesar, Muh Geot Wong, Bhadran Bose, Muralikrishna Gangadharan, Stephen P. McDonald, Chen Au Peh, Sadia Jahan, Chii Yeap, Philip A. Clayton, Georgina Irish, Nikhil Thyagarajan, Peter Hollett, Rathika Krishnasamy, Robert J. Carroll, Shilpanjali Jesudason, Susan Crail, Toby Coates, Jane Waugh, Euan Noble, Kumaradevan Mahadevan, Victoria Campbell, Tania Salehi, Wai H. Lim, Neil Boudville, Aron Chakera, Doris Chan, Anoushka Krishnan, Yusuf Eqbal, Alastair Gillies, Eswari Vilayur, Thida Maung Myint, Nicholas A. Gray, Jane Waugh, Euan Noble, Melissa S Cheetham, Yusuf Eqbal, Peter Hollett, Rathika Krishnasamy, Kumaradevan Mahadevan, Victoria Campbell, Carol A. Pollock, Bruce A. Cooper, Amanda Mather, Sarah Roxburgh, Yvonne Shen, Stefanie Stangenberg, Amanda Siriwardana, Emma O’Lone, Susan Wan, Brendon L. Neuen, Jeffrey T. Ha, Dana Kim, Lauren Heath, Arunima Jain, Elaine Phua, Li Yan, M. W. Gallagher, Meg Jardine, Angus Ritchie, Mona Razavian, Celine Foote, Roger Wyndham, Shaundeep Sen, Zoltán Endre, Jonathan Erlich, Mangalee Fernando, Kenneth Yong
The Lancet. 2023222 CitationsOPEN ACCESS
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Brad H. Rovin, Dawn J. Caster, Daniel C. Cattran, Keisha L. Gibson, Jonathan J. Hogan, Marcus J. Moeller, Dario Roccatello, Michael Cheung, David C. Wheeler, Wolfgang C. Winkelmayer­, Jürgen Floege, Sharon G. Adler, Charles E. Alpers, Isabelle Ayoub, Arvind Bagga, Sean J. Barbour, Jonathan Barratt, Daniel T.M. Chan, Anthony Chang, Jason Choo, H. Terence Cook, Rosanna Coppo, Fernando C. Fervenza, Agnes B. Fogo, J. G. Fox, Richard J. Glassock, David C.H. Harris, Elisabeth M Hodson, Jonathan J. Hogan, Elion Hoxha, Kunitoshi Iseki, J. Charles Jennette, Vivekanand Jha, David W. Johnson, Shinya Kaname, Ritsuko Katafuchi, A. Richard Kitching, Richard A. Lafayette, Philip Kam‐Tao Li, Adrian Liew, Jicheng Lv, Ana Malvar, Shoichi Maruyama, Juan M. Mejía‐Vilet, Chi Chiu Mok, Patrick H. Nachman, Carla Nester, Eisei Noiri, Michelle M. O’Shaughnessy, Seza Özen, Samir M. Parikh, Hyeong Cheon Park, Chen Au Peh, William F. Pendergraft, Matthew C. Pickering, Évangéline Pillebout, Jai Radhakrishnan, Manish Rathi, Pierre Ronco, William E. Smoyer, Sydney Tang, Vladimı́r Tesař, Joshua M. Thurman, Hernán Trimarchi, Marina Vivarelli, Giles Walters, Angela Yee‐Moon Wang, Scott E. Wenderfer, Jack F.M. Wetzels
Kidney International. 2019187 CitationsOPEN ACCESS

Related on ScholarIQ

University of Louisville
Institution
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Paper
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
Paper
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Paper
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial
Paper
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Paper
470M+ articles · free account